Cargando…
Cryotherapy is Associated with Improved Clinical Outcomes of Sorafenib Therapy for Advanced Hepatocellular Carcinoma
We assessed the safety and efficacy of sorafenib with cryotherapy (cryoRx) in advanced hepatocellular carcinoma (HCC). One hundred four HCC patients were enrolled, who met the following criteria: (i) Barcelona Clinic Liver Cancer stage C; (ii) HCC without distant metastasis; (iii) the presence of po...
Autores principales: | Yang, Yongping, Lu, Yinying, Wang, Chunping, Bai, Wenlin, Qu, Jianhui, Chen, Yan, Chang, Xiujuan, An, Linjing, Zhou, Lin, Zeng, Zhen, Lou, Min, Lv, Jiyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353117/ https://www.ncbi.nlm.nih.gov/pubmed/22477032 http://dx.doi.org/10.1007/s12013-012-9353-2 |
Ejemplares similares
-
Outcomes of ultrasound-guided percutaneous argon-helium cryoablation of hepatocellular carcinoma
por: Yang, Yongping, et al.
Publicado: (2011) -
Long-Term Outcomes of Percutaneous Cryoablation for Patients with Hepatocellular Carcinoma within Milan Criteria
por: Rong, Guanghua, et al.
Publicado: (2015) -
LINE-1 ORF-1p enhances the transcription factor activity of pregnenolone X receptor and promotes sorafenib resistance in hepatocellular carcinoma cells
por: Chen, Yan, et al.
Publicado: (2018) -
Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
por: Sanoff, Hanna K., et al.
Publicado: (2016) -
Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma
por: Mousa, Ali Ben
Publicado: (2008)